Projected health-service cost impact of dalbavancin consolidation therapy for Staphylococcus aureus bacteraemia in an Australian public health system
{{output}}
Background: Management of Staphylococcus aureus bacteraemia (SAB) requires prolonged intravenous (IV) antibiotic therapy delivered in hospital or through Hospital in the Home (HITH), often requiring peripherally inserted central ... ...
